Skip to main content
. 2022 Jun;192(6):826–836. doi: 10.1016/j.ajpath.2022.02.004

Table 1.

Major Immune Cells Associated with Liver Cancer

Immune cells Common markers for identification Association with poor prognosis Functions associated with liver cancer
Neutrophils/TANs CD11b, CD66b, Ly6G High population10 Inflammatory responses,20 macrophage recruitment26
Macrophages/TAMs iNOS, CD80, and CD86 for M1 subsets and CD163, CD204, and CD206 for M2 High population10 Inflammatory responses and cytokine secretion26,27,35,36
MDSCs CD33, CD45 High population48,49 Monocyte recruitment,50 immunosuppression51
DCs HLA-DR May differ depending on activation or localization57,59 Regulation of T-cell cytotoxic activity60,61
NK cells CD27, NKG2D Low population68 IFN-γ production,67 anti-tumor cytotoxicity69,70
B cells CD20, CD79a Low population75 Promotion of T-cell activation78
T cells CD3, CD4, CD8 Low population79,80 Cytotoxic activity against tumor cells79, 80, 81
Tregs FOXP3 High population10 Immunosuppression87
Th17 cells CD3+CD4+CD8 High population92 Suggested close relationship with Tregs92,93
Mast cells c-Kit, chymase, tryptase Controversial98,99 Histamine secretion95

c-Kit, receptor tyrosine kinase; DC, dendritic cell; FOXP3, forkhead box P3; HLA-DR, major histocompatibility complex class II DR; IFN, interferon; iNOS, inducible nitric oxide synthase; Ly6G, lymphocyte antigen 6 complex locus G; MDSC, myeloid-derived suppressor cell; NK, natural killer; NKG2D, NK group 2 member D; TAM, tumor-associated macrophage; TAN, tumor-associated neutrophil; Th17, type 17 helper T; Treg, regulatory T cell.